Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NuVasive® Modulus-C Interbody System

K-Number: K172676 · 2017-12-14

Decision Date2017-12-14
Product CodeODP
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

NuVasive® Modulus-C Interbody System is the device name listed in this FDA 510(k) record. The listed applicant is Nu Vasive, Incorporated. It received FDA 510(k) clearance on 2017-12-14 under 510(k) number K172676. The device is classified under product code ODP. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NuVasive® Modulus-C Interbody System?

NuVasive® Modulus-C Interbody System is a medical device that received FDA 510(k) clearance on 2017-12-14. The listed applicant is Nu Vasive, Incorporated. The 510(k) number is K172676.

When did NuVasive® Modulus-C Interbody System receive FDA 510(k) clearance?

NuVasive® Modulus-C Interbody System received FDA 510(k) clearance on 2017-12-14, under 510(k) number K172676.

Who is the listed applicant for NuVasive® Modulus-C Interbody System?

The FDA 510(k) record lists Nu Vasive, Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NuVasive® Modulus-C Interbody System?

The FDA product code for NuVasive® Modulus-C Interbody System is ODP.

Other records listing Nu Vasive, Incorporated as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 79 devices →

Related Devices (Code: ODP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.